TACROLIMUS

Generic: TACROLIMUS

Mylan Pharmaceuticals Inc.Manufacturer
ORALRoute
TACROLIMUSActive Substance
2010-09-17Original Approval

TACROLIMUS is FDA application ANDA090596, sponsored by MYLAN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
12,642 reports
2
DRUG INEFFECTIVE
8,811 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
6,056 reports
4
DRUG INTERACTION
5,550 reports
5
ACUTE KIDNEY INJURY
5,393 reports
6
DIARRHOEA
4,492 reports
7
TRANSPLANT REJECTION
4,073 reports
8
CYTOMEGALOVIRUS INFECTION
4,009 reports
9
PYREXIA
3,812 reports
10
COVID-19
3,720 reports